The inside story of how Ajay Piramal’s pharma empire received a boost after the Abbott sale Industry-The Economic Times — February 12, 2018 comments off The domestic formulations exit was timely and generated funds that were deployed in financial services, realty and information management. Piramal continued to build on fledgling pharma segments.